Clinical Research Directory

Inclusion Criteria: * Hematopoietic Stem Cell Transplant Recipients 1. Adult patients with an expected survival of ≥4 weeks. 2. Confirmed CMV infection, including CMV viremia and CMV disease. 3. Fully understand the content of the trial, voluntarily participate and complete the trial, and voluntarily sign the informed consent form. Exclusion Criteria: * Participants who meet any of the following criteria are not eligible for this study: 1. Patients currently participating in other CMV-related clinical studies, such as those receiving anti-CMV drug treatment or involved in CMV vaccine clinical studies. 2. At screening, liver function tests show: AST \> 5×ULN, or ALT \> 5×ULN, or total bilirubin ≥ 3.0×ULN. 3. Patients with psychiatric disorders or severe psychological conditions that may affect the ability to provide informed consent or participate in follow-up consultations. 4. Participants deemed unsuitable for inclusion by the investigator.